SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F9CA9ED7B95FC6DD186C0B41EB464DE07EAE37F28DBB0973CDB35DDEE6D4F9B8DFD276E0E4110B3282D49F720C0D909A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F9CA9ED7B95FC6DD186C0B41EB464DE07EAE37F28DBB0973CDB35DDEE6D4F9B8DFD276E0E4110B3282D49F720C0D909A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F9CA9ED7B95FC6DD186C0B41EB464DE07EAE37F28DBB0973CDB35DDEE6D4F9B8DFD276E0E4110B3282D49F720C0D909A
http://www.w3.org/2000/01/rdf-schema#comment
"ZEL-H16 is a novel and potent nonimidazole agonist of H3R which might serve as a pharmacological tool for future investigations or as possible therapeutic agent of H3R."
xsd:string
http://purl.uniprot.org/uniprot/#_49241C70C16F2059EF6443B23E0CCF6DB68A849FAAC0DBF1C6A3F2F44C9FA4D9FE1BAD25F245A9D27979EF4536A385AD
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F9CA9ED7B95FC6DD186C0B41EB464DE07EAE37F28DBB0973CDB35DDEE6D4F9B8DFD276E0E4110B3282D49F720C0D909A
http://purl.uniprot.org/uniprot/Q9QYN8
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F9CA9ED7B95FC6DD186C0B41EB464DE07EAE37F28DBB0973CDB35DDEE6D4F9B8DFD276E0E4110B3282D49F720C0D909A
http://purl.uniprot.org/uniprot/#_Q9QYN8-mappedCitation-22870296
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F9CA9ED7B95FC6DD186C0B41EB464DE07EAE37F28DBB0973CDB35DDEE6D4F9B8DFD276E0E4110B3282D49F720C0D909A